Form 4 for EW Edwards Lifesciences
Accepted 2025-08-18 00:00:00 ET · period of report 2025-08-18 · accession 0001225208-25-007321 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-08-18 | 2025-08-18 | EW | Wood Larry L | Gbl Pres TAVR, Surg | M - OptEx | $59.26 | +8,950 | 215.9K | +4% | +$530.4K |
| D | 2025-08-18 | 2025-08-18 | EW | Wood Larry L | Gbl Pres TAVR, Surg | S - Sale+OE | $78.06 | -8,950 | 206.9K | -4% | -$698.6K |
| D | 2025-08-18 | 2025-08-18 | EW | Wood Larry L | Gbl Pres TAVR, Surg | M - OptEx | $0.00 | -8,950 | 35.8K | -20% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-18 | M | A | 8,950 | $59.26 | 215,850.39 | D | — | — | |
| 2 | Common | Common Stock | 2025-08-18 | S | D | 8,950 | $78.06 | 206,900.39 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $77.68 to $78.43. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, uponrequest by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Derivative | Employee Stock Option (Right to Acquire) | 2025-08-18 | M | D | 8,950 | $0.00 | 35,800 | D | $59.26 · 2020-05-08 to 2026-05-07 | 8,950 Common Stock |